07 Jan 2001

Cefakliman® (Cefakliman® Tabletten) - Deutschland

Updated: 07 Jan 2001


Klimakterische Ausfallserscheinungen.

Cefakliman® Description, Presentation and Dosage

Cefakliman® Description

Cefakliman® Drug Class Description


Cefakliman® Drug Description

1 Tbl. enth.: Lachesis D12 10 mg, Cimicifuga D5 10 mg, Sepia D5 10 mg, Lilium tigrinum D5 10 mg.

Cefakliman® Generic Name

Cefakliman® Tabletten

Cefakliman® Presentation

Cefakliman® Presentation


Cefakliman® Manufacturer


Related Learning Zones

CSU Knowledge Centre

CSU Knowledge Centre

This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In this resource, you will find a disease overview, symposia highlights platform, video channel and additional resources including an events calendar and useful external links.

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current prevalence statistics, treatment options, current diagnosis criteria from WHO and ADA, and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and a free CME activity titled the ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’. The CME is EACCME-accredited and worth 1 European CME credit (ECMEC). 

Cefakliman® Dosage

Cefakliman® Adult Dosage

Lactose, Magnesiumstearat.

Cefakliman® Precautions, Reactions and Contraindications

Cefakliman® Special Precautions

Related Drugs - Women's Health and Obs/Gyn

Back to top